This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): ADC730
Description: WEE-1 is an oral, selective inhibitor that targets the Wee1-like protein kinase.
WEE-1 (Almac) News
Additional information available to subscribers only: